Sklan, D., E
Why the Dual Targeting Matters While GLP-1 receptor agonists like semaglutide are already successful in treating type 2 diabetes, combining it with GIP signaling unlocks greater benefits
Localized peripheral deficits, often at higher frequencies, can induce compensatory plasticity within central auditory circuits that extends beyond the original site of damage, producing percepts at dissociated frequencies 7,10,11
So when you remove the GLP-1 medication, that patient is set back on a course of weight increase. In other words, without the medication to block and promote pathways that can affect a bodys biochemistry, a person is more likely to return to consuming more calories and regaining weight
Int J Psychiatry Clin Pract
Beyond providing the injections themselves, weight loss clinics often offer comprehensive weight loss programs that include FDA approved appetite suppressants, nutritional counseling, fitness plans, and additional weight loss support